Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. GlaxoSmithKline Manufacturing S.p.A.
FDA Inspection
•GlaxoSmithKline Manufacturing S.p.A.•May 27, 2015

GlaxoSmithKline Manufacturing S.p.A. – FDA Inspection, May 27, 2015

Record Details

This FDA Inspection record concerns GlaxoSmithKline Manufacturing S.p.A., with an inspection on May 27, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
GlaxoSmithKline Manufacturing S.p.A.
Inspection Date
May 27, 2015
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 11cd01a9-b7be-4ff7-a6b9-3b7a7148d1b7

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
934049
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

8
  1. 21 CFR 211.180(b)Record maintenance 1 year (except exempt OTC)
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.194(a)Complete test data included in records
  5. 21 CFR 211.113(b)Procedures for sterile drug products
  6. 21 CFR 211.165(a)Testing and release for distribution
  7. 21 CFR 211.22(c)Approve or reject procedures or specs
  8. 21 CFR 211.22(a)Approve or reject components, products

Full citation text and observation details available on the Dashboard.

Other FDA inspections of GlaxoSmithKline Manufacturing S.p.A.

7
DateClassificationOfficeProject area
May 15, 2025Not classifiedOffice of Inspections and Investigations
October 26, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 29, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 22, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 10, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for GlaxoSmithKline Manufacturing S.p.A.
  • FDA Inspection 1285374 - 2025-05-15
  • FDA Inspection 1244033 - 2023-10-26
  • FDA Inspection 1064045 - 2017-09-29
  • FDA Inspection 982333 - 2016-07-22
  • FDA Inspection 842545 - 2013-07-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GlaxoSmithKline Manufacturing S.p.A.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.